Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome

Am J Med Genet. 1999 Dec 3;87(4):366-8.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Acetylcarnitine / therapeutic use*
  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / etiology
  • Child
  • Double-Blind Method
  • Fragile X Syndrome / complications*
  • Humans
  • Male
  • Nootropic Agents / therapeutic use*
  • Statistics as Topic
  • Treatment Outcome

Substances

  • Nootropic Agents
  • Acetylcarnitine